NCT02571036 2023-12-13A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced MalignanciesDeciphera Pharmaceuticals, LLCPhase 1 Completed282 enrolled
NCT02498665 2023-11-14A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesSumitomo Pharma America, Inc.Phase 1 Completed24 enrolled
NCT02012231 2020-10-19Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Fore BiotherapeuticsPhase 1 Terminated5 enrolled
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT00039091 2018-09-05Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 1 Terminated26 enrolled
NCT00073944 2013-05-30BCX-1777 in Treating Patients With Refractory CancerNational Cancer Institute (NCI)Phase 1 Completed